[HTML][HTML] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, L Martín, R Mangues… - Microbial cell …, 2016 - Springer
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, M Lucas, R Mangues… - Microbial Cell …, 2016 - search.proquest.com
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
Recombinant Pharmaceuticals from microbial cells: a 2015 update.
L Sanchez-Garcia, L Martín, R Mangues… - Microbial Cell …, 2016 - search.ebscohost.com
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
[PDF][PDF] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez‑Garcia, L Martín, R Mangues… - 2016 - core.ac.uk
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
Recombinant pharmaceuticals from microbial cells: A 2015 update
L Sanchez-Garcia, L Martín, R Mangues… - Microbial Cell …, 2016 - portalrecerca.uab.cat
Abstract© 2016 Sanchez-Garcia et al. Diabetes, growth or clotting disorders are among the
spectrum of human diseases related to protein absence or malfunction. Since these …
spectrum of human diseases related to protein absence or malfunction. Since these …
[PDF][PDF] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez‑Garcia, L Martín, R Mangues… - 2016 - scienceopen.com
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, L Martín, R Mangues… - Microbial cell …, 2016 - ddd.uab.cat
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
[HTML][HTML] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, L Martín, R Mangues… - Microbial Cell …, 2016 - ncbi.nlm.nih.gov
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
[PDF][PDF] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez‑Garcia, L Martín, R Mangues… - 2016 - cyberleninka.org
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
protein absence or mal‑function. Since these pathologies cannot be yet regularly treated by …
[HTML][HTML] Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, L Martín… - Microbial Cell …, 2016 - microbialcellfactories.biomedcentral …
Diabetes, growth or clotting disorders are among the spectrum of human diseases related to
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …
protein absence or malfunction. Since these pathologies cannot be yet regularly treated by …